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Delayed enhancement cardiovascular magnetic resonance (MR) is the gold-standard for non-
invasive assessment after myocardial infarction (Mi). MR microscopy (MRM) provides a level of detail 
comparable to the macro objective of light microscopy. We used MRM and correlative histopathology to 
identify infarct and remote tissue in contrast agent-free multi-sequence MRM in swine Mi hearts. one 








maps based on MRM images clearly delineated the infarcted regions. As a proof of concept, these 
results illustrate the potential of MRM with correlative histopathology as a platform for exploring novel 
contrast agent-free MR biomarkers after MI.
Delayed enhancement cardiovascular magnetic resonance (MR) is the most used imaging technique for com-
prehensive non-invasive assessment of the structural consequences of myocardial infarction (MI) in patients1. 
However, limitations to the use of contrast in cardiovascular MR include the risk of side effects and the length 
of the studies2. Therefore, it seems important to advance towards contrast agent-free, histologically-validated 
cardiovascular MR biomarkers.
Each sequence of a cardiac MR study provides specific information, which when taken together provides a 
comprehensive picture of the cardiac structure. T1-weighted images show the cardiac anatomic structure, T1 
values rise with increased extracellular volume, while T2-weighted images are related with the magnitude of 
the myocardial oedema3,4. Novel sequences recently incorporated into the clinical armamentarium are designed 
to indirectly evaluate fibrotic tissue (T1-post contrast and extracellular volume fraction), the presence of 
oedema during the acute post-MI phase (T1-mapping5,6), and the extent of haemorrhage in the infarcted area 
(T2*-mapping2). Despite the benefits provided by endogenous contrast in T1, T2, and T2* images and the design 
of new sequences, gadolinium-enhanced cardiac MR remains the routine tool in Post-Infarction imaging. Its 
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high tissue contrast makes it the method of choice to measure infarct size and determine the transmural extent 
of infarction7,8.
The term MR microscopy (MRM) refers to ultra-high resolution (<100 µm) MR imaging. This resolution 
is lower than that of light microscopy (0.25 µm), but much higher than clinical MR (approximately 1 mm in 
plane resolution)9. Thus, MRM provides a more detailed functional and anatomical picture of tissue than clinical 
MR. In addition, ultra-high resolution technology is becoming more accessible to clinics, and some studies have 
shown promising results on the utility of cardiac images from a 7T scanner10,11. Histopathological validation 
could act as a bridge between MRM and clinical MR12–14 and help develop novel contrast agent-free cardiovascu-
lar MR biomarkers in the field of myocardial diseases.
The end-point of the present study was to illustrate the potential of contrast agent-free MRM and correlative 
histopathology as a source of future cardiovascular MR biomarkers. For this purpose, and as a proof of concept, 
we tested the accuracy of this methodology in highly-controlled swine models of acute and chronic MI to identify 
the most characteristic structural consequence in this scenario, namely the presence of infarcted tissue. The spe-
cific objectives were: (1) to distinguish between infarcted and remote areas (in the acute and chronic MI settings) 
by contrast agent-free MRM sequences, identified and validated by correlative histopathology. (2) To analyse 
the value of combined MRM parameters using multivariate discrimination models for the same purpose. (3) To 
represent the information provided by the merged multivariate models in pixel-by-pixel probabilistic maps for 
intuitive tissue classification and easier interpretation.
Results
One control group (n = 3 swine) and two experimental MI groups (one acute and other chronic) were formed: 
90 min of ischemia were followed by 1 week (acute MI, n = 6 swine) or 1 month (chronic MI, n = 5 swine) 
reperfusion.
Briefly, following heart excision, infarct and remote myocardial samples from each heart were isolated and 
measured in the 14 T MRM equipment. These same samples were then histologically stained to identify remote 
and infarct areas. The images obtained from the histology were then compared with those derived from MRM in 
order to identify the remote and infarct areas in the MRM images (Fig. 1).
MR microscopy of the acute and chronic Mi groups. Acute MI group. In comparison to the uniform 
signal intensity of the remote tissue, the great heterogeneity in signal intensity shown by infarcted tissue in T1, T2, 
and T2* MRM images allowed us to clearly differentiate between both tissue types (Fig. 1A).
In the acute MI, T2 and T2* values from infarct areas were lower and with larger standard deviation in com-
parison to remote tissue (Fig. 2 upper panel). This reflects that the acute infarcted tissue is more active, and 
different process (oedema, infiltration and necrotic tissues) are occurring at those moments. The high inter- and 
intra-sample heterogeneity in acute MI samples is due to the heterogeneous composition of the infarcted region.
Figure 1. Histopathological sections and magnetic resonance microscopy images of an acute and a chronic MI 
experiment. Left panel showing acute MI images (A): Histopathological stain with haematoxylin-eosin (a,e), 
T1-weighted imaging (b,f), T2-weighted imaging (c,g) and T2*-weighted image (d,h) for remote and infarcted 
tissues respectively. Right panel showing chronic MI images (B): Histopathological stains with HE (i,n) and 
picrosirius red (j,o), T1-weighted imaging (k,p), T2-weighted imaging (l,q) and T2*-weighted imaging (m,r) 
for remote and infarcted tissues respectively. Connective tissue is marked with a black arrow, pericardium is 
marked with a white arrow and a vessel is marked with a black dot. Areas with and without necrosis (A) or 
fibrosis (B) (shown by histopathology) can be easily distinguished in terms of image intensity by magnetic 
resonance microscopy. Abbreviations: HE = haematoxylin-eosin; MI = myocardial infarction; T1 = longitudinal 
relaxation; T2 = transversal relaxation; T2* = effective transversal relaxation.
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In the infarcted area, the histopathological examination identified oedema, inflammatory infiltrate and necro-
sis (Fig. S1). Haematoxylin staining highlighted areas of leucocyte accumulation, typical of the inflammatory 
infiltrate. And eosin staining revealed the accumulated inner liquid of the cytoplasm, as well as the necrotic cells, 
that has lost the limits. In T2-weighted imaging, regions with severe inflammatory infiltrate showed as dark 
spotted areas. Oedematous areas appeared grey, and necrotic areas displayed bright tones in all three sequences 
(Fig. 1A).
ANOVA analysis was used to compare remote, infarct and control for T1 signal intensity values, T2 map val-
ues, and T2* map values. Differences for control-remote, control-infarct and remote-infarct were all statistically 
significant (p < 0.05) (Table S1).
Chronic MI group. An excellent correlation existed between histopathological staining and MRM images 
derived from T1, T2 and T2* weighted images (Fig. 1B) in this setting. Under MRM, infarcted areas appeared 
predominantly hyper-intense with hypo-intense splashes. This is indicative of tissue damage repair by a collagen 
scar.
This pathological evolution resulted in reversed quantified values of T2 and T2* for chronic with respect to 
acute infarcted samples, reflecting the replacement of oedema and inflammatory infiltration by collagen deposi-
tion in chronic MI samples. The remote tissue exhibited low intra- and inter-sample heterogeneity and a higher 
standard deviation than the remote tissue from the acute model. Moreover, the values of all three sequences from 
the infarcted tissue of the chronic model increased substantially due to the formation of collagen scar (Fig. 2 lower 
panel).
For this group, we also compared infarct, remote and control areas for each of the three sequences. As in the 
acute MI group, differences for control-remote, control-infarct and remote-infarct areas were highly significant 
(p < 0.001) (Table S1).
Multimodal analysis to differentiate between infarcted and remote regions.  Acute MI model. 
Cross validation error rate for the acute infarct model was 15.71% (44/280). Specificity and sensitivity of this 
model in correctly identifying infarct and remote regions of interest (ROIs) were 0.92 (92/100) and 0.80 (144/180), 
respectively. Root mean square cross validation error was 0.52 for the remote tissue and 0.75 for the infarcted tis-
sue. In the acute infarct partial least squares discriminant analysis (PLS-DA) model, the latent variable (LV) 1 (X 
axis) explained 52.33% of dataset variance. The loading plot for this LV1 revealed that T1 ratio, T2* mean, and T2 
Figure 2. Boxplots representing magnetic resonance microscopy parameters in acute and chronic MI 
experiments. Box-and-whisker plots showing T1 signal intensity ratio (a,d), T2 map (b,e), and T2* map (c,f) for 
remote and infarct areas in acute (upper panel) and chronic (lower panel) MI hearts. Boxes denote interquartile 
range, lines denote median, and whiskers denote tenth and ninetieth percentiles. The statistical significance 
is shown for each sequence between infarct and remote tissue (**p < 0.01). Abbreviations: au = arbitrary 
units; MI = myocardial infarction; T1 = longitudinal relaxation; T2 = transversal relaxation; T2* = effective 
transversal relaxation.
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standard deviation contributed the most to the direction of discrimination. The LV2 (Y axis) explained 22.54% 
of dataset variance. T2* standard deviation contributed the most to LV2 according to its loading plot (Fig. 3a).
Chronic MI model. Cross validation error rate for the chronic infarct model was 0.69% (2/290). This indicates 
that the merged multi-sequence model permits an excellent discrimination between the infarcted and the remote 
tissue in the chronic MI model. The specificity and sensitivity of the chronic MI PLS-DA model in correctly iden-
tifying ROIs sampled from the infarcted area were 1.00 (140/140) and 0.99 (148/150), respectively. Root mean 
square cross validation error in chronic infarct samples was 0.57 for the remote tissue and 0.60 for the infarcted 
tissue.
In the chronic MI PLS-DA model, the LV1 explained 42.29% of dataset variance and perfectly differentiated 
between the infarcted and the remote tissue (X axis). The loading plot for this LV1 revealed that T2* with its 
standard deviation contributed the most to this axis. The LV2 explained 22.48% of dataset variance (Y axis). T2 
and its standard deviation contributed the most to LV2 according to the loading plots (Fig. 3b).
probabilistic images. Thus, once the T1 virtual variable (T1 signal intensity mean/T1 signal inten-
sity sd ratio) and, T2 and T2* relaxation times mean and its standard deviation matrixes were combined in 
multi-sequence approaches, the resulting PLS-DA multivariate models for acute and chronic MI discriminated 
between infarcted and remote tissue with high specificity and sensitivity. We built probabilistic images to easily 
visualize these results.
The probability of a given ROI, based on the merged PLS-DA models, of belonging to either the infarcted or 
remote tissue was graphically represented: red for infarcted tissue and blue for remote tissue. Figure 4 displays the 
probabilistic maps for samples obtained from the remote and the infarcted tissue in both the acute and chronic 
MI models.
Discussion
The main contribution of the present study is that it illustrates the possibilities of contrast agent-free multise-
quence MRM with correlative histopathology as a platform to investigate and develop new MR biomarkers in 
the field of myocardial diseases with a potential for translation into the clinic. As a proof of concept, our results 
demonstrate that this approach permits an accurate identification of the most relevant features of myocardial 
damage following MI, namely the magnitude of necrotic (in acute phase) and fibrotic (in chronic phase) tissue. 
We have previously used this approach in the evaluation of brain tumours15, but to our knowledge this is the 
first study in myocardial samples. The methodology applied in the present study could form the basis for future 
research aimed at investigating new contrast agent-free cardiovascular MR biomarkers in myocardial diseases.
Figure 3. Scores and loading plots of the PLS-DA models to differentiate between the infarct and the remote 
areas in magnetic resonance microscopy images of acute and chronic MI samples. Axes correspond to latent 
variables that explain more than 50% of data variability. Both the acute (a) and chronic (b) models were able 
to discriminate between the infarct (red points) and the remote (blue) areas. The merged PLS-DA model 
for chronic MI permitted an excellent differentiation between remote and infarcted tissue. Abbreviations: 
LV = latent variable; MI = myocardial infarction; PLS-DA = partial least squares discriminant analysis; 
SD = standard deviation; T1 = longitudinal relaxation; T2 = transversal relaxation; T2* = effective transversal 
relaxation.
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The use of a 14 T scanner with a spatial resolution higher than conventional MR permitted the visualization of 
small myocardial samples in high microstructural detail. Imaging was carried out with conventional cardiac MR 
sequences (T1-weighted, T2 and T2* maps)7 and samples were embedded in an agarose matrix for subsequent 
matching of MRM images with light microscopy. Histopathology by optical microscopy ensured the correct inter-
pretation of the different MRM images and a better identification of the microstructural elements present in the 
samples. At 14 T, without an additional contrast agent, the images were sufficiently detailed to identify the major 
structural components of the tissue. For direct co-registration of MRM and histopathology, we requested both 
histological and MRM virtual slices in the plane of maximal area. As shown in Fig. 1, MRM had a similar resolu-
tion to histology of the macro objective of the light microscope. Correlating MRM images with histopathology 
was key to identifying microstructural properties in specific regions of interest defined by the histologist.
MRM quantification revealed differences in T2 and T2* values between chronic and acute infarct samples. 
Haematoxylin-eosin staining revealed a heterogeneous tissue composition (oedema, necrosis, and inflammatory 
infiltrate) in the acute phase2, which may explain the high intra- and inter-sample heterogeneity detected in the 
acute infarct model. In contrast, as found in previous studies16–18, in chronic infarct samples oedema had already 
vanished and a homogeneous scar with high collagen content (as shown from picrosirius red stain) had substi-
tuted most of the damaged tissue. This explains why T2 and T2* were much more consistent in the chronic MI 
model.
Although each individual MRM sequence displayed some microstructural elements, only the combined 
multi-sequence analyses provided specific characteristic patterns that revealed pathologically-relevant struc-
tures. Other studies performed with both visual and quantitative MR have shown that it is not always possible to 
distinguish between infarcted and remote regions in a single sequence19. In the present study, the use of PLS-DA 
multivariable models to simultaneously analyse multi-sequence MRM images and extract the most valuable data 
from each was decisive in precisely differentiating between infarcted and remote areas.
Figure 4. Magnetic resonance microscopy probabilistic maps of myocardial samples obtained from swine 
infarcted hearts. The probabilistic maps used a red-blue colour code to represent the combined probability 
(based on the respective PLS-DA models) of the tissue being infarcted (red) or remote (blue). The correlative 
histopathology is also shown. Remote areas (acute infarction: A,B; chronic infarction: E,F) and infarct areas 
(acute infarction: C,D; chronic infarction: G,H) are displayed in the left and right panels respectively. An 
agarose-hiding mask has been applied to the map to better visualize images. Abbreviations: HE = haematoxylin-
eosin; PLS-DA = partial least squares discriminant analysis.
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Our findings reveal that not only image intensity, but also intra- and inter-region variability, expressed as 
standard deviations, contribute decisively to discrimination. Thus, beyond changes in the nature of the tissue, the 
high degree of heterogeneity present in the infarcted myocardium (especially in acute phase) alters its functional 
properties and must also be taken into account in detection. This accurate discrimination probably reflects the 
higher homogeneity exhibited by the chronic infarcted tissue when compared with the unstable condition and 
heterogeneous composition of the infarcted tissue in the acute MI group. The almost perfect accuracy (99% 
sensitivity, 100% specificity) of the PLS-DA model in detecting fibrotic areas in the chronic MI group reflects the 
virtues of the presented methodology.
Expert operators are accustomed to interpreting MR images. However, the simultaneous use of several images 
and sequences over the same anatomical regions is often a cumbersome task and subjective4. Combining the 
mathematical data derived from PLS-DA models to provide a simple probabilistic view represents a user-friendly 
approach that facilitates the analysis for MR operators. By combining all sequences used in a 3D matrix and 
running each pixel through the PLS-DA model, we obtain a pixel-by-pixel probability matrix that expresses 
the probability of each pixel belonging to remote or infarct tissue. The conversion of this information into a 
3D matrix classifies the different regions of the infarcted heart with a pixel-by-pixel RGB code and generates 
easy-to-interpret parametric maps. The similarity between our probabilistic images and the histological evalua-
tion of the same samples illustrates the reliability of this approach.
In routine cardiovascular MR, late gadolinium enhancement permits a reliable quantification of necrotic 
and fibrotic tissue after MI. As mentioned above, the use of gadolinium contrast can exert deleterious effects 
on patients with poor kidney function, prolong studies and reduce lab efficiency. Recently, contrast agent-free 
T1ρ20,21, native T1 map6,22,23 and diffusion-weighted24 imaging have been incorporated for this purpose. The pres-
ent study does not aim to substitute these well-validated indexes.
Our results illustrate the potential of MRM using multivariable methodology applied in a 14 T field without 
additional contrast to properly identify the major structural components of myocardial tissue indicated and con-
firmed by histopathology. This approach, tested in the present study as a proof of concept to detect necrotic and 
fibrotic tissue in experimental acute and chronic swine MI models, could be used in future as a platform to gener-
ate an in-vivo model for obtaining new potential cardiovascular MR biomarkers that could be translated into the 
clinic in the field of myocardial diseases.
The translation of this approach into clinical field strengths will be complex but is feasible. Generation of the 
MR signal is based on the same physical principles regardless of field strength. Although important limitations 
prevent direct translation (removed blood effects, main magnetic field, B0 inhomogeneities, partial tissue deg-
radation, etc.), the described methodology can reveal MR parameters with potential as clinical MR biomark-
ers. Although these potential biomarkers suffer from many limitations they could help direct future clinical MR 
biomarker research into more meaningful directions and aid in the interpretation in terms of histopathological 
events. The final clinical biomarker development and validation, based on high-field findings, should be per-
formed in clinical scanners.
Our study suffers the inherent limitations of studies performed on experimental samples that advise caution 
on the translation of such findings to clinical MR imaging. For example, the physical and physiological conditions 
of the tissue directly affect the MRM parameters. The data herein presented are a first step to show the potential 
of MRM and correlative histopathology as a source of new cardiovascular MR biomarkers and as a platform to 
improve the pathological understanding of cardiovascular MR findings after MI.
Materials and Methods
Study in the experimental swine model of reperfused MI.  The study was approved by the Animal 
Care and Use Committee of the University of Valencia and conformed to the Guide for the Care and Use of 
Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication No. 85–23, revised 
1996) and to The ARRIVE guidelines (www.nc3rs.org.uk/ARRIVE).
Experimental protocol. Well established experimental swine models of acute and chronic MI were used. 
Experiments were coordinated by the veterinarian of the University of Valencia, who has participated for more 
than 10 years in the development of our swine infarction model. After fasting for at least 12 h, juvenile domestic 
pigs weighing 25–30 kg were sedated using intra-muscular 8 mg kg−1 ketamine and 0.1 mg kg−1 medetomidine, 
and anesthetized using 10 mg kg−1 h−1 continuous intra-venous infusion of 2% propofol. The right jugular vein 
was cannulised to administer drugs and to obtain blood samples. Before the intervention, intra-venous amiodar-
one (300 mg) and lidocaine (30 mg) were administered to the pigs to diminish life-threatening arrhythmias, and 
heparin (3000 U) to diminish the formation of thrombus. Animals were mechanically ventilated using a 50% oxy-
gen gas mixture and continuously monitored through electrocardiogram for heart rate, rhythm, and ST-segment 
changes. An interventional cardiologist with 9 years’ experience performed cardiac catheterizations.
A 7F sheath was introduced into the right femoral artery to monitor blood pressure and to access the left ante-
rior descending coronary artery. A 7F Amplatz Left 0.75 catheter was used to selectively engage the left coronary 
artery, and a standard hydrophilic angioplasty wire was advanced and placed in the left distal anterior descending 
coronary artery. A 2.5 × 15 mm over-the-wire angioplasty balloon was inflated to 6 atm immediately distal to the 
first diagonal branch and coronary artery occlusion was confirmed by contrast injection and by electrocardio-
graphic ST-segment elevation. Additional details on our experimental models can be consulted elsewhere14,25,26.
Experimental groups. One control group and two MI (acute and chronic) experimental groups were formed. In 
the MI groups, after 90-min occlusion of the mid-left anterior descending artery by an angioplasty balloon, exper-
iments were categorized as follows: (1) 1-week (n = 6, acute MI) and (2) 1-month (n = 5, chronic MI) reperfusion. 
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The control group (n = 3) was subjected to the same experimental protocol used in the MI groups, but without 
angioplasty balloon inflation, thus ischemia and infarction were not induced.
Macroscopic study of the infarct and remote regions. Once the reperfusion period was completed (1 week in acute 
MI, 1 month in chronic MI), cardiac catheterization was repeated under the same conditions used in the first pro-
cedure. In order to determine the area at risk, 20 mL of 4% thioflavin-S (TS) (Sigma Aldrich, St Louis, MO, USA) 
solution were injected distally into the coronary artery through the lumen of the over-the-wire balloon inflated at 
the same point and to the same pressure as that used to induce MI. Finally, the heart was arrested with potassium 
chloride and excised in all cases14,25,26.
The left ventricle of the excised heart was sectioned into 5-mm thick short-axis slices. Pieces were incubated in 
2% 2,3,5-triphenyltetrazolium chloride (TTZ) solution (Sigma Aldrich, St Louis, MO, USA) at 37 °C for 20 min-
utes to determine the infarcted area. The infarcted area was defined as myocardium with simultaneous TS (within 
the area at risk) and without TTZ uptake, whereas myocardium with TTZ uptake (non-infarcted) and without TS 
uptake (out of the area at risk) was considered as remote myocardium (Fig. 5)14,25,26.
Sample preparation for MRi. Samples, each approximately 1 × 1 × 0.50 cm3, were taken from the infarcted 
and remote areas in each of the animals. Overall, 36 myocardial samples were obtained and classified into 3 
groups: infarcted myocardium (7 chronic and 9 acute), remote myocardium (7 chronic and 5 acute) and controls 
(8 samples). Samples were preserved at −80 °C until further measurement.
Magnetic resonance microscopy. Immediately before MRM acquisition, samples were embedded in a 
2.5% agarose matrix (Agarose Low EEO, Scharlau, Barcelona, Spain) and placed inside a Ø 1 cm nuclear MR tube. 
MRM images were acquired at room temperature (25 °C) in a 14 T vertical axis imager (Bruker-AVANCE 600 
system, Bruker Biospin GmbH, Rheinstetten, Germany) equipped with a 10 mm microimaging 1H coil tuned to 
Figure 5. Macroscopic heart sections from the acute (left panels) and chronic (right panels) myocardial 
infarction groups. Upper panels (a,b): Area at risk corresponds to tissue stained with thioflavin-S (light blue). 
Lower panels (c,d): The infarcted tissue corresponds to 2,3,5-Triphenyltetrazolium non-stained myocardium. 
Samples were obtained from the acute (c: I-infarct, II-remote) and chronic infarct models (d: III-infarct and IV-
remote) and stained with haematoxylin-eosin.
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the appropriate proton frequency. The acquisition software was ParaVision 4 (Bruker Biospin GmbH, Ettlingen, 
Germany).
Slice orientation was selected to provide the largest in-plane tissue area. Maximal gradient strength was 210 
gauss cm−1. Matrix resolution was 256 × 256 pixels. The field of view was adjusted for each sample to improve 
the resolution. Slice thickness was 0.50 mm without gap. Our standard protocol for imaging lasted 9 hours and 
consisted of rapid acquisition with refocusing echo sequences to obtain T1- and T2-weighted imaging with the 
following repetition time and echo time (TR/TE) values: T1-weighted imaging, 1500 ms/9.3 ms and excitation 
flip angle 90°; T2-weighted imaging: 4000 ms/38.4 ms and excitation flip angle 90°. The acquisition bandwidth 
for the T1 experiment was set to 3.6 kHz and 128 signal averages were acquired, leading to a total scan time of 
2 hours, 33 minutes and 36 seconds. The acquisition bandwidth for the T2 experiment was set to 2.7 kHz and 64 
signal averages were acquired, leading to a total scan time of 3 hours, 24 minutes and 48 seconds. Multi gradient 
echo pulse sequences were also acquired to obtain T2*-weighted imaging with TR/TE values of 2000 ms/9 ms 
and excitation flip angle 30°. The acquisition bandwidth for the T2* experiment was set to 5.4 kHz and 8 signal 
average was acquired, leading to a total scan time of 51 minutes and 12 seconds. We also performed multi slice, 
multi echo pulse sequences to T2 mapping (TR of 2500 ms and 16 echos ranging from 9.8 to 156.4 ms, excitation 
flip angle of 90°) and multi gradient echo pulse sequences to T2* mapping (TR of 2000 ms and 12 echos starting at 
4 ms with 6 ms intervals, excitation flip angle of 30°). The acquisition bandwidth for the T2- mapping experiment 
was set to 3 kHz and 16 signal averages were acquired, leading to a total scan time of 2 hours and 8 minutes. The 
acquisition bandwidth for the T2*- mapping experiment was set to 5.4 kHz and 8 signal averages were acquired, 
leading to a total scan time of 51 minutes and 12 seconds. This measurement system allows an almost free choice 
of virtual slice selection and orientation. The maps were calculated with the t2vtr equation. Depending on the 
sequence used, in-plane spatial resolutions achieved up to 35 µm per pixel. Table 1 shows the MR sequences 
parameters used.
The quality of the images from each sequence was evaluated by quantifying the signal-noise-ratio for the 
chronic (Table S2) and acute (Table S3) MI groups. To calculate the signal-noise-ratio, the following formula was 
employed: ROIsignal mean/ROInoise SD27,28.
Histopathological analysis. After MRM, the agarose matrix was removed and the sample rinsed in a 4% 
formaldehyde solution (Formol 4% Buffered, VWR, Radnor, PA, USA). The sample was then embedded in par-
affin and sliced (5 µm thickness) using a Leica RM2145 microtome (Leica Microsystems, Weztlar, Germany). 
Histological slicing orientation was chosen to match the MRM images following the maximal sample area criteria.
Characterization of histological slices was performed using conventional haematoxylin-eosin stain. 
Haematoxylin-eosin is the most used staining in medical diagnosis. Haematoxylin stains cell nuclei blue, and 
eosin stains the cytoplasms and extracellular matrix pink.
Additionally, in samples obtained from chronic MI experiments, the presence and distribution of collagen 
fibres were assessed using picrosirius red stain26. An optical microscope at 20x magnification (Leica DMD 108, 
Leica Microsystems, Weztlar, Germany) was used to capture images of all samples. A polarizing filter was applied 
to slices stained with picrosirius red (Direct Red 80, Sigma Aldrich, St Louis, MO, USA).
Data analysis, chemometric classification models and probabilistic images.  Based on histopa-
thology, we first established that MRM sequences accurately discriminate between infarct and remote regions in 
both MI group (acute and chronic) images. The information provided by each MR sequence was combined to 
create a PLS-DA model for both MI groups (acute and chronic). We aimed to evaluate the accuracy of the merged 
multi-sequence models to properly distinguish between ROI obtained from the infarcted and remote areas.
In histopathological and in MRM slices, we identified common anatomical reference points to confirm loca-
tion14. In each slice, we defined 10 square ROIs of 0.01 cm2 each. For samples from acute MI experiments, we 
selected 100 ROIs of remote tissue and 180 ROIs of infarcted tissue. We selected 160 ROIs from control tissue. 
For samples from chronic MI experiments, we selected 140 ROIs of remote tissue and 150 ROIs of infarcted tis-
sue. Dataset was transferred into the mathematical environment Matlab R2013a (8.1.0.604 Natick, MA, USA). 
Statistical significance was tested using ANOVA test (p-value < 0.05) (Table S1).
SEQUENCES
TR 







T1-weighted imaging 1500 9.3 1 128 4 90° 256 × 256 RARE 12
T2-weighted imaging 4000 38.4 1 64 4 90° 256 × 256 RARE 12
T2*-weighted imaging 2000 9 1 8 — 30° 256 × 256 MGE 12
T2- multiecho sequences 2500 From 9.8 to 156 16 16 — 90° 256 × 256 MSME 12
T2*- multiecho sequences 2000 From 4 to 70 12 8 — 30° 256 × 256 MGE 12
Table 1. Parameters of the magnetic resonance microscopy sequences employed. Abbreviations: MGE = multi 
gradient echo sequence; MSME = multi slice, multi echo pulse sequence; RARE = rapid acquisition with 
refocusing echo sequence; RF = RARE factor; T1 = longitudinal relaxation; T2 = transversal relaxation; 
T2* = effective transversal relaxation; TE = echo time; TR = repetition time.
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For each ROI we calculated the mean and the standard deviation of T1-weighted intensities, T2 values, and 
T2* values. In order to quantitatively compare the homogeneity of T1 images between samples, we calculated the 
ratio between T1-weighted intensity mean and the corresponding standard deviation.
We then built PLS-DA models to differentiate between ROI groups (infarcted or remote) that included T1 
ratio, T2 mean, T2 standard deviation, T2* mean and T2* standard deviation. PLS toolbox v8.0.2 (Eigenvector 
research, Inc., Manson, WS, USA) was used for this purpose. PLS-DA is a linear classification method based on 
the partial least squares regression algorithm. It is used to build a quantitative model for classification by project-
ing the predicted and observable variables into a new space to maximize the covariance between the response 
and independent variables. PLS-DA suggested using the first two LVs. The models were cross-validated using the 
venetian blinds approach. Receiver-operating characteristic curves were calculated for cross validation. Finally, 
we translated the classification of each pixel according to the PLS-DA models into probabilistic images for easier 
interpretation.
As our models were strongly dependent on the standard deviation of the different sequences applied to the 
selected ROIs, we calculated the apparent standard deviation for each pixel. This apparent standard deviation was 
calculated from the pixel selected and the neighbouring pixels in all directions. For statistical precision, the T1 
signal intensity of weighted images, and T2 and T2* relaxation times for each pixel was substituted by the mean of 
the 4 pixels used for the calculation of the standard deviation. To calculate the probability of each pixel belonging 
to either the infarcted or the remote area, we ran all the pixels of each slice for each sample through the corre-
sponding acute or chronic PLS-DA model. The PLS-DA model provided the information for RGB probabilistic 
maps. The probability of each pixel being classified as infarcted or remote corresponded to the relative intensity 
of the R or B channels respectively. The G channel was suppressed to avoid interference. The new RGB 3D matrix 
was flattened and overlaid in order to obtain the parametric map, providing a quantitative, pixel-by-pixel classi-
fication of the cardiac tissue.
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